Considering that recent evidence indicates that DPYD may play a role in breast cancer metastasis2, it would be interesting to determine if a DPYD inhibitor might provide added benefit to patients by limiting toxicity as well as targeting tumors that undergo EMT. This evidence concerns the gene DPYD and breast carcinoma.